‘The Rock’ asks families to be Diabetes Aware in new PSA
NEW YORK The fact of the matter is the average person is inundated with more than 3,000 messages each day, and as a result has gotten pretty good at tuning most of those messages out. So breaking through that clutter with a Hollywood star that may make fans pause for even a second around an important healthcare message is an accomplishment in and of itself.
And if you look at the caliber of stars who have participated in breaking through that clutter with Novo Nordisk and the Entertainment Industry Foundation — Halle Berry, Dustin Hoffman and Kevin Kline — Dwayne "The Rock" Johnson is joining some pretty elite, attention-grabbing company.
And it doesn’t hurt that Novo Nordisk and the Entertainment Industry Foundation have chosen a popular family/action/adventure star to herald increased awareness around diabetes, either. Johnson’s most recent box office release — Walt Disney’s "Race to Witch Mountain" — already has grossed $106.4 million worldwide, which includes $67.2 million domestically. And the movie became available on DVD Aug. 4, which means Johnson will be top of mind among those movie buffs who recently made a trip to Blockbuster Video or checked their mailbox for their latest Netflix flick.
Medication adherence report reveals need for patient-specific interventions
NEW YORK Boehringer Ingelheim has done a major service to the industry with the release of this report. Closing the gap on patient compliance and adherence remains not only the best opportunity for retail pharmacy to grow the business at a time of waning big blockbuster drug introductions and continued pressure from generic competition, but also represents the best opportunity for this industry to “show what it’s got,” as the entire nation turn its attention to health reform.
Hundreds of billions of healthcare dollars are spent needlessly as a result of people not taking their medications as they are supposed to, to say nothing of the toll it’s taking on patient outcomes.
Reading between the lines here, one of the big reasons behind non-compliance could very well be the state of the economy. A public opinion poll of 1,025 adults conducted by the Kaiser Family Foundation in mid-July found that 49% of Americans are still taking cost-cutting measures when it comes to their healthcare: 33% are shifting to medicines available over-the-counter in favor of a doctor’s visit; 21% skipped a doctor-recommended medical test or treatment because of cost; and 15% cut prescription doses in half or skipped doses in an effort to stretch their medicines. And taking those kinds of cost-cutting measures — saving a co-pay today but risking an emergency room visit tomorrow — only helps to amplify the important role a pharmacist can play in helping their patients navigate cost-saving strategies in an effort to maintain/boost compliance.
“All of those things…are happening,” Ted Epperly, president of the American Academy of Family Physicians, told Drug Store News in the fall following a similar Kaiser survey, and its cutting deeper than just the working poor, he said. Patients who would fall into lower- and middle-income status are making similar cost-cutting decisions.
Also already happening is that pharmacist interceding on the patient’s behalf to help mitigate prescription-drug costs. “We’ve found that physicians were particularly receptive to calling on a patient’s behalf and giving suggestions on how that patient could save money, especially if it was a matter of a patient either not taking that medication at all or taking something [else] to address their condition,” Douglas Hoey, SVP and COO for the National Community Pharmacy Association, told Drug Store News this past fall.
Study: Stomach bugs increase risk of IBD
NEW YORK Diarrheal disease may increase a person’s risk of developing inflammatory bowel disease, according to a study published in Gastroenterology.
IBD refers to a group of conditions, including Crohn’s disease and ulcerative colitis, marked by chronic inflammation in the intestines, leading to such symptoms as abdominal pain and diarrhea.
Henrik Nielsen, M.D., from Aarhaus University Hospital in Aalborg, Denmark, and colleagues reported in the latest issue of the journal that over the course of 7.5 years, IBD was diagnosed for the first time in far more gastroenteritis patients 1.2% of patients were diagnosed with IBD, compared with 0.5% of healthy control subjects.
Nielsen and colleagues compared the risks of IBD between 13,148 patients with documented gastroenteritis caused by salmonella or campylobacter and 26,216 uninfected controls.
Stomach bug patients had nearly a threefold increased risk of developing IBD over the entire study period, and nearly a twofold increased risk in the first year after infection.